RGNX Smart Money
REGENXBIO Inc.
1W: -8.0%
1M: -11.1%
3M: -31.5%
YTD: -51.5%
1Y: -47.7%
3Y: -58.6%
5Y: -81.4%
$6.60
+0.02 (+0.30%)
After Hours: $7.19 (+0.59, +8.94%)
Weekly Expected Move ±8.5%
$6
$6
$7
$7
$8
Credit Risk of going bust: higher than 81% of companies Debt: 13.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.19 (down 97%), REGENXBIO Inc. would be worth roughly what it owes.
Total debt $69.0M against a stock market value of $434.4M.
Distance to default 2.51 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $34.5M (short-term plus half of long-term), stock volatility 96.4%; Altman Z'' -9.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.19 (down 97%), REGENXBIO Inc. would be worth roughly what it owes.
Total debt $69.0M against a stock market value of $434.4M.
Distance to default 2.51 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $34.5M (short-term plus half of long-term), stock volatility 96.4%; Altman Z'' -9.90. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026202
Institutions Holding
-1 vs prior
116.8%
Ownership
+35.43%
26
New
61
Increased
87
Reduced
35
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Chan Mitchell | officer: chief financial officer | F-Tax Withholding | 4,902 | $9.32 | $46K | Filing |
| 2026-09-01 | Malzahn Craig | officer: chief technology officer | F-Tax Withholding | 234 | $9.32 | $2K | Filing |
| 2026-08-27 | Ciongoli Gregory Austin | director | P-Purchase | 53,407 | $9.36 | $500K | Filing |
| 2026-08-26 | Ciongoli Gregory Austin | director | P-Purchase | 49,196 | $9.14 | $450K | Filing |
| 2026-08-25 | Ciongoli Gregory Austin | director | A-Grant/Award | 15,432 | $— | $0 | Filing |
| 2026-08-01 | PAKOLA STEVE | officer: chief medical officer | F-Tax Withholding | 7,468 | $9.69 | $72K | Filing |
| 2026-08-01 | Christmas Patrick J. | officer: chief strategy & legal officer | F-Tax Withholding | 4,699 | $9.69 | $46K | Filing |
| 2026-07-02 | PAKOLA STEVE | officer: chief medical officer | S-Sale | 2,161 | $13.64 | $29K | Filing |
| 2026-07-01 | PAKOLA STEVE | officer: chief medical officer | S-Sale | 36,725 | $12.86 | $472K | Filing |
| 2026-07-01 | Simpson Curran | officer: chief executive officer | F-Tax Withholding | 6,818 | $13.09 | $89K | Filing |
| 2026-06-30 | Simpson Curran | officer: chief executive officer | A-Grant/Award | 1,453 | $10.18 | $15K | Filing |
| 2026-06-29 | PAKOLA STEVE | officer: chief medical officer | S-Sale | 19,608 | $11.04 | $216K | Filing |
| 2026-05-29 | Bennett Jean | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | Zachary Jennifer | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | MIGAUSKY GEORGE V | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | KARABELAS ARGERIS N | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | STUMP DAVID C | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | Mills Kenneth T. | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | Fox Allan M. | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | Glucksmann Alexandra | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-29 | Tasse Daniel | director | A-Grant/Award | 9,807 | $— | $0 | Filing |
| 2026-05-11 | PAKOLA STEVE | officer: chief medical officer | S-Sale | 15,309 | $11.02 | $169K | Filing |
| 2026-03-10 | PAKOLA STEVE | officer: chief medical officer | S-Sale | 5,124 | $10.35 | $53K | Filing |
| 2026-02-01 | PAKOLA STEVE | officer: chief medical officer | F-Tax Withholding | 5,267 | $11.16 | $59K | Filing |
| 2026-02-01 | Christmas Patrick J. | officer: chief strategy & legal officer | F-Tax Withholding | 4,700 | $11.16 | $52K | Filing |
🏛️ Congressional Trades
2 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2019-11-08 | Peter Welch | House | Sell | $1,001 - $15,000 | Filing |
| 2019-10-22 | Peter Welch | House | Buy | $1,001 - $15,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 6,397,440 | $77M | +614,632 | 2026-06-30 | Filing |
| Redmile Group, LLC | 4,368,804 | $52M | — | 2026-06-30 | Filing |
| STATE STREET CORP | 2,971,173 | $36M | +239,688 | 2026-06-30 | Filing |
| JPMORGAN CHASE & CO | 2,214,169 | $26M | -1,269,631 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,107,557 | $25M | +100,411 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,953,237 | $23M | -112,920 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,421,453 | $17M | -418,010 | 2026-06-30 | Filing |
| AQR CAPITAL MANAGEMENT LLC | 1,378,358 | $17M | +326,646 | 2026-06-30 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,355,554 | $16M | +336,653 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 1,284,950 | $15M | +1,284,950 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,241,296 | $15M | +103,798 | 2026-06-30 | Filing |
| Integral Health Asset Management, LLC | 800,000 | $10M | -700,000 | 2026-06-30 | Filing |
| Nuveen, LLC | 740,026 | $9M | +158,010 | 2026-06-30 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 731,586 | $9M | -278,795 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 712,814 | $9M | +426,813 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 669,808 | $8M | +114,916 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 669,023 | $8M | +669,023 | 2026-06-30 | Filing |
| STIFEL FINANCIAL CORP | 560,727 | $7M | +167,958 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 518,545 | $6M | +193,685 | 2026-06-30 | Filing |
| 22NW, LP | 492,759 | $6M | — | 2026-06-30 | Filing |